close

Fundraisings and IPOs

1 66 67 68 69 70 75
Number of results: 1487
Date Company Amount Funding type Investors Therapeutic area Type of Information
2011-11-11 Genable Technologies (Ireland) € 5 million series B financing round Fountain Healthcare Partners (ireland) Delta Partners (USA - CA) Rare diseases - Genetic diseases Series B financing round
2011-11-08 ORCA Therapeutics (The Netherlands) € 5 million credit Agentschap NL (The Netherlands) Cancer - Oncology Subvention
2011-11-07 Somantix (The Netherlands) VU University Medical Center Amsterdam (The Netherlands) € 1.5 million grant EuroTransBio (European Commission initiative to foster cross border research & development between companies and academia working in the biotech industry) (UE) Cancer - Oncology Grant
2011-11-04 Genfit (France) €93,500 private placement Yorkville Advisors LLC (USA) Cardiovascular diseases - Metabolic diseases - Liver diseases Private placement
2011-11-03 Curevac (Germany) $110 Million (€100 million) private placement Baillie Gifford (UK) Chartwave Limited (UK) Coppel family, Elma Investments, Sigma Group, dievini Hopp BioTech holding (Germany) Dietmar Hopp (Germany) the Bill & Melinda Gates Foundation (USA) Cancer - Oncology Private placement
2011-11-02 Fresenius (Germany) €100 million private placement via issuance of senior notes
2011-11-02 Genfit (France) €500,000 private placement Cardiovascular diseases - Metabolic diseases - Liver diseases Private placement
2011-11-01 Domainex (UK) £250,000 (€ 291 156) grant Technology Strategy Board (UK) Cancer - Oncology Grant
2011-10-27 Bind Biosciences (USA - MA) $47.25 million series D financing round Rusnano (Russian Federation) DHK Investment (India) Polaris Venture Partners (USA - MA) ARCH Venture Partners (USA - IL) Endeavour Vision (Switzerland) NanoDimension (USA - CA) private investors Series D financing round
2011-10-26 OctoPlus (the Netherlands) €4 million private placement Technology - Services Private placement
2011-10-26 Curetis (Germany) Expansion of the financing round by € 9.6 million Infectious diseases Fundraising
2011-10-25 Prosensa (The Netherlands) up to €5 million credit AgentschapNL (The Netherlands) Rare diseases - Neuromuscular diseases Subvention
2011-10-19 Arsanis Biosciences (Austria) € 1.19 million grant Austrian Research Promotion Agency (Austria) Infectious diseases Grant
2011-10-18 Population Genetics (UK) $5.7 million (€4.15 million) Technology - Services Fundraising
2011-10-17 Hookipa Biotech (Austria) €7 million series A financing round Infectious diseases Fundraising
2011-10-17 Hoopika Biotech (Austria) €7 million series A financing round Sofinnova Partners (France) Forbion Capital Partners (The Netherlands) Cancer - Oncology - Infectious diseases Series A financing round
2011-10-12 Affiris (Austria) $ 1.5 million (€ 1.08 million) grant The Michael J. Fox Foundation - MJFF (USA) Neurodegenerative diseases Grant
2011-10-11 The EUROCALIN Consortium The Consortium consists of Pieris AG (Germany), as project coordinator; Technische Universität München (Germany); Medical University of Innsbruck (Austria); Radboud University Nijmegen Medical Centre (Netherlands); Covance Laboratories Ltd. (UK); Antitope Ltd. (UK); FUJIFILM Diosynth Biotechnologies Ltd.UK Limited (UK); Coriolis Pharma Research GmbH (Germany); FGK Clinical Research GmbH (Germany); and ConsulTech GmbH (Germany). €6 million grant Grant
2011-10-03 Tigenix (Belgium) €4.95 million loan Madrid Network Allergic diseases - Immunological diseases Subvention
2011-10-00 Viroblock (Switzerland) CHF 3.3 million (€2.6 million) series C financing round Infectious diseases Fundraising